Breakthrough in Vision Restoration: Opus Genetics' LCA5 Study Results

In this video, we explore the latest findings from Opus Genetics' Phase 1/2 clinical trial on OPGx-LCA5, a promising treatment for inherited retinal degeneration. Discover how pediatric participants aged 16-17 experienced significant improvements in vision after a single subretinal injection. We discuss the implications of a 0.3 logMAR improvement and enhanced cone sensitivity to light, showcasing the potential for restoring vision in those with profound vision loss. Additionally, we highlight the sustained improvements observed in adult participants over 18 months. Join us as we delve into the future of vision restoration and the upcoming discussions with the FDA regarding the LCA5 program.

Видео Breakthrough in Vision Restoration: Opus Genetics' LCA5 Study Results канала Star & Sports Daily